Safety and tolerability of Ga-NT-20.3, a radiopharmaceutical for targeting neurotensin receptors, in patients with pancreatic ductal adenocarcinoma: the first in-human use.
European journal of nuclear medicine and molecular imaging Apr, 2021 | Pubmed ID: 33006657